Report Detail

Pharma & Healthcare Global and United States Rosuvastatin Market Insights, Forecast to 2026

  • RnM4191268
  • |
  • 07 September, 2020
  • |
  • Global
  • |
  • 141 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Rosuvastatin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rosuvastatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Rosuvastatin market is segmented into
Purity 98.0%
Purity 99.0%
Other

Segment by Application, the Rosuvastatin market is segmented into
Tablet
Capsule
Others

Regional and Country-level Analysis
The Rosuvastatin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rosuvastatin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Rosuvastatin Market Share Analysis
Rosuvastatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rosuvastatin business, the date to enter into the Rosuvastatin market, Rosuvastatin product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences


1 Study Coverage

  • 1.1 Rosuvastatin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Rosuvastatin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Rosuvastatin Market Size Growth Rate by Type
    • 1.4.2 Purity 98.0%
    • 1.4.3 Purity 99.0%
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Rosuvastatin Market Size Growth Rate by Application
    • 1.5.2 Tablet
    • 1.5.3 Capsule
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Rosuvastatin Market Size, Estimates and Forecasts
    • 2.1.1 Global Rosuvastatin Revenue 2015-2026
    • 2.1.2 Global Rosuvastatin Sales 2015-2026
  • 2.2 Global Rosuvastatin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Rosuvastatin Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Rosuvastatin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Rosuvastatin Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Rosuvastatin Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Rosuvastatin Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Rosuvastatin Revenue Forecast by Region (2021-2026)

3 Global Rosuvastatin Competitor Landscape by Players

  • 3.1 Global Top Rosuvastatin Sales by Manufacturers
    • 3.1.1 Global Rosuvastatin Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Rosuvastatin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Rosuvastatin Manufacturers by Revenue
    • 3.2.1 Global Rosuvastatin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Rosuvastatin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Rosuvastatin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Rosuvastatin Revenue in 2019
    • 3.2.5 Global Rosuvastatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Rosuvastatin Price by Manufacturers
  • 3.4 Global Rosuvastatin Manufacturing Base Distribution, Product Types
    • 3.4.1 Rosuvastatin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Rosuvastatin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Rosuvastatin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Rosuvastatin Market Size by Type (2015-2020)
    • 4.1.1 Global Rosuvastatin Sales by Type (2015-2020)
    • 4.1.2 Global Rosuvastatin Revenue by Type (2015-2020)
    • 4.1.3 Rosuvastatin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Rosuvastatin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Rosuvastatin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Rosuvastatin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Rosuvastatin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Rosuvastatin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Rosuvastatin Market Size by Application (2015-2020)
    • 5.1.1 Global Rosuvastatin Sales by Application (2015-2020)
    • 5.1.2 Global Rosuvastatin Revenue by Application (2015-2020)
    • 5.1.3 Rosuvastatin Price by Application (2015-2020)
  • 5.2 Rosuvastatin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Rosuvastatin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Rosuvastatin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Rosuvastatin Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Rosuvastatin Market Size YoY Growth 2015-2026
    • 6.1.1 United States Rosuvastatin Sales YoY Growth 2015-2026
    • 6.1.2 United States Rosuvastatin Revenue YoY Growth 2015-2026
    • 6.1.3 United States Rosuvastatin Market Share in Global Market 2015-2026
  • 6.2 United States Rosuvastatin Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Rosuvastatin Players by Sales (2015-2020)
    • 6.2.2 United States Top Rosuvastatin Players by Revenue (2015-2020)
  • 6.3 United States Rosuvastatin Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Rosuvastatin Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Rosuvastatin Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Rosuvastatin Price by Type (2015-2020)
  • 6.4 United States Rosuvastatin Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Rosuvastatin Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Rosuvastatin Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Rosuvastatin Price Forecast by Type (2021-2026)
  • 6.5 United States Rosuvastatin Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Rosuvastatin Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Rosuvastatin Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Rosuvastatin Price by Application (2015-2020)
  • 6.6 United States Rosuvastatin Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Rosuvastatin Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Rosuvastatin Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Rosuvastatin Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Rosuvastatin Market Size YoY Growth 2015-2026
  • 7.2 North America Rosuvastatin Market Facts & Figures by Country
    • 7.2.1 North America Rosuvastatin Sales by Country (2015-2020)
    • 7.2.2 North America Rosuvastatin Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Rosuvastatin Market Size YoY Growth 2015-2026
  • 8.2 Europe Rosuvastatin Market Facts & Figures by Country
    • 8.2.1 Europe Rosuvastatin Sales by Country
    • 8.2.2 Europe Rosuvastatin Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Rosuvastatin Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Rosuvastatin Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Rosuvastatin Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Rosuvastatin Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Rosuvastatin Market Size YoY Growth 2015-2026
  • 10.2 Latin America Rosuvastatin Market Facts & Figures by Country
    • 10.2.1 Latin America Rosuvastatin Sales by Country
    • 10.2.2 Latin America Rosuvastatin Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Rosuvastatin Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Rosuvastatin Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Rosuvastatin Sales by Country
    • 11.2.2 Middle East and Africa Rosuvastatin Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 AstraZeneca
    • 12.1.1 AstraZeneca Corporation Information
    • 12.1.2 AstraZeneca Description and Business Overview
    • 12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 AstraZeneca Rosuvastatin Products Offered
    • 12.1.5 AstraZeneca Recent Development
  • 12.2 Teva Pharmaceutical Industries
    • 12.2.1 Teva Pharmaceutical Industries Corporation Information
    • 12.2.2 Teva Pharmaceutical Industries Description and Business Overview
    • 12.2.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Teva Pharmaceutical Industries Rosuvastatin Products Offered
    • 12.2.5 Teva Pharmaceutical Industries Recent Development
  • 12.3 MSN Laboratories
    • 12.3.1 MSN Laboratories Corporation Information
    • 12.3.2 MSN Laboratories Description and Business Overview
    • 12.3.3 MSN Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 MSN Laboratories Rosuvastatin Products Offered
    • 12.3.5 MSN Laboratories Recent Development
  • 12.4 Cadila Pharmaceuticals
    • 12.4.1 Cadila Pharmaceuticals Corporation Information
    • 12.4.2 Cadila Pharmaceuticals Description and Business Overview
    • 12.4.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Cadila Pharmaceuticals Rosuvastatin Products Offered
    • 12.4.5 Cadila Pharmaceuticals Recent Development
  • 12.5 LGM Pharma
    • 12.5.1 LGM Pharma Corporation Information
    • 12.5.2 LGM Pharma Description and Business Overview
    • 12.5.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 LGM Pharma Rosuvastatin Products Offered
    • 12.5.5 LGM Pharma Recent Development
  • 12.6 Bal Pharma
    • 12.6.1 Bal Pharma Corporation Information
    • 12.6.2 Bal Pharma Description and Business Overview
    • 12.6.3 Bal Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Bal Pharma Rosuvastatin Products Offered
    • 12.6.5 Bal Pharma Recent Development
  • 12.7 Changzhou Pharmaceutical Factory
    • 12.7.1 Changzhou Pharmaceutical Factory Corporation Information
    • 12.7.2 Changzhou Pharmaceutical Factory Description and Business Overview
    • 12.7.3 Changzhou Pharmaceutical Factory Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Products Offered
    • 12.7.5 Changzhou Pharmaceutical Factory Recent Development
  • 12.8 Jingxin Pharm
    • 12.8.1 Jingxin Pharm Corporation Information
    • 12.8.2 Jingxin Pharm Description and Business Overview
    • 12.8.3 Jingxin Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Jingxin Pharm Rosuvastatin Products Offered
    • 12.8.5 Jingxin Pharm Recent Development
  • 12.9 Zhejiang Hisun Pharmaceutical
    • 12.9.1 Zhejiang Hisun Pharmaceutical Corporation Information
    • 12.9.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
    • 12.9.3 Zhejiang Hisun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Products Offered
    • 12.9.5 Zhejiang Hisun Pharmaceutical Recent Development
  • 12.10 HEC Pharm
    • 12.10.1 HEC Pharm Corporation Information
    • 12.10.2 HEC Pharm Description and Business Overview
    • 12.10.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 HEC Pharm Rosuvastatin Products Offered
    • 12.10.5 HEC Pharm Recent Development
  • 12.11 AstraZeneca
    • 12.11.1 AstraZeneca Corporation Information
    • 12.11.2 AstraZeneca Description and Business Overview
    • 12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 AstraZeneca Rosuvastatin Products Offered
    • 12.11.5 AstraZeneca Recent Development
  • 12.12 Nanjing Frochem Tech
    • 12.12.1 Nanjing Frochem Tech Corporation Information
    • 12.12.2 Nanjing Frochem Tech Description and Business Overview
    • 12.12.3 Nanjing Frochem Tech Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 Nanjing Frochem Tech Products Offered
    • 12.12.5 Nanjing Frochem Tech Recent Development
  • 12.13 Lianyungang Runzhong Pharmaceutical
    • 12.13.1 Lianyungang Runzhong Pharmaceutical Corporation Information
    • 12.13.2 Lianyungang Runzhong Pharmaceutical Description and Business Overview
    • 12.13.3 Lianyungang Runzhong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 Lianyungang Runzhong Pharmaceutical Products Offered
    • 12.13.5 Lianyungang Runzhong Pharmaceutical Recent Development
  • 12.14 Shandong Bechem Chemicals
    • 12.14.1 Shandong Bechem Chemicals Corporation Information
    • 12.14.2 Shandong Bechem Chemicals Description and Business Overview
    • 12.14.3 Shandong Bechem Chemicals Sales, Revenue and Gross Margin (2015-2020)
    • 12.14.4 Shandong Bechem Chemicals Products Offered
    • 12.14.5 Shandong Bechem Chemicals Recent Development
  • 12.15 CTX Life Sciences
    • 12.15.1 CTX Life Sciences Corporation Information
    • 12.15.2 CTX Life Sciences Description and Business Overview
    • 12.15.3 CTX Life Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 12.15.4 CTX Life Sciences Products Offered
    • 12.15.5 CTX Life Sciences Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Rosuvastatin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Rosuvastatin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Rosuvastatin. Industry analysis & Market Report on Rosuvastatin is a syndicated market report, published as Global and United States Rosuvastatin Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Rosuvastatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,630.90
    5,446.35
    7,261.80
    595,491.00
    893,236.50
    1,190,982.00
    329,160.00
    493,740.00
    658,320.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report